Search - tctmd.com

Displaying 401 - 420 of 440

Sort: Relevancy | Date

News Daily News

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Leah Lawrence

August 23, 2011

News Daily News

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

Caitlin E. Cox

August 05, 2011

News Daily News

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

L.A. McKeown

August 05, 2011

News Daily News

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Caitlin E. Cox

August 03, 2011

News Daily News

Meta-analysis Finds Equivalence Between First-, Second-Generation DES

L.A. McKeown

August 02, 2011

News Industry News

Micell Technologies Completes Enrollment in DESSOLVE II Study of the MiStent® Drug-Eluting Coronary Stent

July 26, 2011

News Daily News

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Jason Kahn

July 21, 2011

News Industry News

CID SpA announces the CE mark of its new Cre8™ Polymer-Free DES

July 19, 2011

News Daily News

DES Show Advantage over BMS for Heart Transplant Complication

L.A. McKeown

July 01, 2011

News Industry News

Sahajanand Medical Technologies, India Receives CE Mark on Two Sirolimus Eluting Coronary Stents

June 26, 2011

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Caitlin E. Cox

June 24, 2011

News Daily News

Cordis Announces Plans to Discontinue Cypher Stents, Drop Nevo Development

L.A. McKeown

June 15, 2011

News Industry News

Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent

June 15, 2011

News Daily News

EES Show Long-term Safety Advantage over SES

L.A. McKeown

May 24, 2011

News Conference News

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Caitlin E. Cox

May 20, 2011

News Conference News

Long-Term Imaging Study Evaluates Vascular Healing in First-Gen DES

Jason Kahn

May 19, 2011

News Industry News

Axxess™ Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Three Years

May 19, 2011

News Daily News

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Leah Lawrence

April 26, 2011

News Conference News

Therapies Take on In-Stent Restenosis with Mixed Results

Caitlin E. Cox

April 15, 2011

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

L.A. McKeown

April 15, 2011

Advertisement

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Meta-analysis Finds Equivalence Between First-, Second-Generation DES

Micell Technologies Completes Enrollment in DESSOLVE II Study of the MiStent® Drug-Eluting Coronary Stent

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

CID SpA announces the CE mark of its new Cre8™ Polymer-Free DES

DES Show Advantage over BMS for Heart Transplant Complication

Sahajanand Medical Technologies, India Receives CE Mark on Two Sirolimus Eluting Coronary Stents

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Cordis Announces Plans to Discontinue Cypher Stents, Drop Nevo Development

Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent

EES Show Long-term Safety Advantage over SES

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Long-Term Imaging Study Evaluates Vascular Healing in First-Gen DES

Axxess™ Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Three Years

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Therapies Take on In-Stent Restenosis with Mixed Results

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content